Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Non Operating Income: 2020-2025

Historic Non Operating Income for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to $1.9 million.

  • Caribou Biosciences' Non Operating Income fell 47.89% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 90.55%. This contributed to the annual value of $17.5 million for FY2024, which is 23.41% up from last year.
  • Latest data reveals that Caribou Biosciences reported Non Operating Income of $1.9 million as of Q3 2025, which was up 128.40% from -$6.5 million recorded in Q2 2025.
  • Caribou Biosciences' 5-year Non Operating Income high stood at $5.8 million for Q2 2024, and its period low was -$6.5 million during Q2 2025.
  • In the last 3 years, Caribou Biosciences' Non Operating Income had a median value of $3.3 million in 2023 and averaged $2.7 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first plummeted by 2,940.96% in 2021, then skyrocketed by 10,931.25% in 2022.
  • Caribou Biosciences' Non Operating Income (Quarterly) stood at $2.2 million in 2021, then surged by 62.84% to $3.7 million in 2022, then dropped by 14.46% to $3.1 million in 2023, then grew by 7.86% to $3.4 million in 2024, then plummeted by 47.89% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, -$6.5 million for Q2 2025, and $2.9 million during Q1 2025.